Join the club for FREE to access the whole archive and other member benefits.

Bayshore latest drug maker to recall metformin after carcinogens found

21-Aug-2020

Key points from article :

High levels of a probable carcinogen found in samples of the common diabetes medication.

FDA has has spotted a sixth drugmaker with a contaminated version of the drug.

Bayshore Pharmaceuticals has voluntarily recalled one lot each of its extended-release metformin.

FDA found high levels of probable carcinogen N-nitrosodimethylamine (NDMA) in tested samples.

Lots were manufactured by Beximco Pharmaceuticals in Bangladesh, in June 2019 for U.S. distribution.

Both Bayshore and Beximco say they have not been notified of any side effects.

Last month, Lupin Pharmaceuticals pulled discovered high levels of NDMA in their sample lots.

Also, Virginia-based Granules Pharmaceuticals pulled its own version of extended-release metformin.

Other drugmakers which launched their own recalls include Apotex, Teva, Amneal and Marksans,

A good example of why you have to be careful buying meds - even big pharma has problems.

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Health Organisation

US-based manufacturer of generic drugs.

Company

Manufacturer of generic medicines.

Company

Privately-held full service pharmaceutical sales and marketing company.

Company

Leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh.

Company

Ensuring safety of drugs, medical supplies and food which is used daily.

Health Organisation

Generic pharmaceutical company.

Company

A global pharmaceutical company.

Company

Company focused on Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage.

Company

Company developing, producing and marketing affordable, high quality generic drugs and specialty pharmaceuticals.